Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong.

Take two mins to learn more

Qkine

Qkine

Qkine

At the forefront of stem cell therapy and regenerative medicine, Qkine manufactures high-purity, animal-free growth factors. Their expertise in protein purification and structural biology has confirmed their status as a key player in the growth factor market, with over 40 products on the market.

At the forefront of stem cell therapy and regenerative medicine, Qkine manufactures high-purity, animal-free growth factors. Their expertise in protein purification and structural biology has confirmed their status as a key player in the growth factor market, with over 40 products on the market.

A photo of the Qkine team standing outside of a building
A photo of the Qkine team standing outside of a building
A photo of a lab technician in a lab

Why did we invest in

Why did we invest in

Qkine

Qkine

?

?

  • Strong leadership: Senior execs with proven scale-up and IPO experience including 5 exits.

  • High revenue growth: 40%YoY revenue growth whilst moving into profitability. Qkine has global customers in 23 countries.

  • Breakthrough tech: Scalable, animal-free growth factors—30% proprietary, unmatched purity.

  • Big market, high value exits: £270B+ sector with recent M&A at premium revenue multiples.

  • Value add ascertained: Strategic fit with CPI—joint scale-up projects already underway.

Get in Touch with Our Team.

Get in Touch with Our Team.

Get in Touch with Our Team.

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by